An anti-tumor role for cGMP-dependent protein kinase

Cancer Letters

Volumn 240, Issue 1, 2006, Pages 60-68

  Hou, Yali ^a   Gupta, Naren ^a   Schoenlein, Patricia ^a   Wong, Elsie ^a   Martindale, Robert ^a   Ganapathy, Vadivel ^a   Browning, Darren ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

cGMP; Colon cancer; Gene expression; Nude mouse; Protein kinase; Tumor

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TRANSCRIPTION, GENETIC; TRANSFECTION;

MUS MUSCULUS;

EID: 33745869420     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.035     Document Type: Article

References (38)

1. Aoshiba K., Yasui S., Hayashi M., Tamaoki J., and Nagai A. Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J. Immunol. 162 (1999) 1692-1700
2. Boerth N.J., Dey N.B., Cornwell T.L., and Lincoln T.M. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J. Vasc. Res. 34 (1997) 245-259
3. Brophy C.M., Woodrum D.A., Pollock J., Dickinson M., Komalavilas P., Cornwell T.L., et al. cGMP-dependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J. Vasc. Res. 39 (2002) 95-103
4. Browning D.D., Mc Shane M., Marty C., and Ye R.D. Functional analysis of type 1alpha cGMP-dependent protein kinase using green fluorescent fusion proteins. J. Biol. Chem. 276 (2001) 13039-13048
5. Browning D.D., McShane M.P., Marty C., and Ye R.D. Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J. Biol. Chem. 275 (2000) 2811-2816
6. Brunetti M., Mascetra N., Manarini S., Martelli N., Cerletti C., Musiani P., et al. Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis. Biochem. Biophys. Res. Commun. 297 (2002) 498-501
7. Bunn Jr. P.A., Chan D.C., Earle K., Zhao T.L., Helfrich B., Kelly K., et al. Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer. Semin. Oncol. 29 (2002) 87-94
8. Chan D.C., Earle K.A., Zhao T.L., Helfrich B., Zeng C., Baron A., et al. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin. Cancer Res. 8 (2002) 904-912
9. Fogh J., Fogh J.M., and Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl Cancer Inst. 59 (1977) 221-226
10. Francis S.H., and Corbin J.D. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci. 36 (1999) 275-328
11. Frattola L., Tonini C., Villani R., Trabucchi M., and Basal. cAMP- and cGMP-dependent protein kinases in human brain tumors. Acta Neurol. Scand. 60 (1979) 344-351
12. Gagos S., Hopwood V.L., Iliopoulos D., Kostakis A., Karayannakos P., Yatzides H., et al. Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient. Anticancer Res. 15 (1995) 369-378
13. Geiselhoringer A., Gaisa M., Hofmann F., and Schlossmann J. Distribution of IRAG and cGKI-isoforms in murine tissues. Fed. Eur. Biochem. Soc. Lett. 575 (2004) 19-22
14. Goluboff E.T. Exisulind, a selective apoptotic antineoplastic drug. Expert Opin. Investig. Drugs 10 (2001) 1875-1882
15. Haanen C. Sulindac and its derivatives: a novel class of anticancer agents. Curr. Opin. Investig. Drugs 2 (2001) 677-683
16. Han E.K., Arber N., Yamamoto H., Lim J.T., Delohery T., Pamukcu R., et al. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res. Treat. 48 (1998) 195-203
17. Hewitt R.E., McMarlin A., Kleiner D., Wersto R., Martin P., Tsokos M., et al. Validation of a model of colon cancer progression. J. Pathol. 192 (2000) 446-454
18. Hood J., and Granger H.J. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J. Biol. Chem. 273 (1998) 23504-23508
19. Hou Y., Lascola J., Dulin N.O., Ye R.D., and Browning D.D. Activation of cGMP-dependent protein kinase by protein kinase C. J. Biol. Chem. 278 (2003) 16706-16712
20. Huang Y., He Q., Hillman M.J., Rong R., and Sheikh M.S. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res. 61 (2001) 6918-6924
21. Kim Y.M., Chung H.T., Kim S.S., Han J.A., Yoo Y.M., Kim K.M., et al. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J. Neurosci. 19 (1999) 6740-6747
22. Komalavilas P., Shah P.K., Jo H., and Lincoln T.M. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274 (1999) 34301-34309
23. Lincoln T.M., Dey N., and Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J. Appl. Physiol. 91 (2001) 1421-1430
24. Liu L., Li H., Underwood T., Lloyd M., David M., Sperl G., et al. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J. Pharmacol. Exp. Ther. 299 (2001) 583-592
25. Loweth A.C., Williams G.T., Scarpello J.H., and Morgan N.G. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. Fed. Euro. Biochem. Soc. Lett. 400 (1997) 285-288
26. McAlhany S.J., Ressler S.J., Larsen M., Tuxhorn J.A., Yang F., Dang T.D., et al. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res. 63 (2003) 5859-5865
27. Orstavik S., Natarajan V., Tasken K., Jahnsen T., and Sandberg M. Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). Genomics 42 (1997) 311-318
28. Orstavik S., Solberg R., Tasken K., Nordahl M., Altherr M.R., Hansson V., et al. Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 220 (1996) 759-765
29. Piazza G.A., Thompson W.J., Pamukcu R., Alila H.W., Whitehead C.M., Liu L., et al. A novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res. 61 (2001) 3961-3968
30. Ruth P. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol. Ther. 82 (1999) 355-372
31. Segawa K., Minami K., Shiga Y., Shiraishi M., Sata T., Nakashima Y., et al. Inhibitory effects of nicorandil on rat mesangial cell proliferation via the protein kinase G pathway. Nephron 87 (2001) 263-268
32. Sellak H., Yang X., Cao X., Cornwell T., Soff G.A., and Lincoln T. Sp1 transcription factor as a molecular target for nitric oxide- and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase-Ialpha expression in vascular smooth muscle cells. Circ. Res. 90 (2002) 405-412
33. Shimojo T., Hiroe M., Ishiyama S., Ito H., Nishikawa T., and Marumo F. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp. Cell Res. 247 (1999) 38-47
34. Soff G.A., Cornwell T.L., Cundiff D.L., Gately S., and Lincoln T.M. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J. Clin. Invest. 100 (1997) 2580-2587
35. Takuma K., Phuagphong P., Lee E., Mori K., Baba A., and Matsuda T. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 276 (2001) 48093-48099
36. Thompson H.J., Jiang C., Lu J., Mehta R.G., Piazza G.A., Paranka N.S., et al. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 57 (1997) 267-271
37. Thompson W.J., Piazza G.A., Li H., Liu L., Fetter J., Zhu B., et al. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res. 60 (2000) 3338-3342
38. Wong A.S., Kim S.O., Leung P.C., Auersperg N., and Pelech S.L. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium. Gynecol. Oncol. 82 (2001) 305-311